HRT Financial’s GeoVax Labs GOVX Stock Holding History

HRT Financial’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,409	Closed	-$31K	–	4147
2025 Q4	$31K	Buy	+7,409	New	+$81.5K	﹤0.01%	2937
2022 Q4	–	Sell	-31	Closed	-$12K	–	2715
2022 Q3	$12K	Buy	+31	New	+$17.9K	﹤0.01%	2523

Other funds holding GOVX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HRT Financial's GOVX Position: Q1 2026 in Review

HRT Financial sold out of GeoVax Labs (GOVX) in Q1 2026, closing a stake of 7,409 shares — an estimated $31K sold.

HRT Financial first reported a position in GOVX in Q3 2022 and held it in 2 quarters. The position peaked at $31K in Q4 2025. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2026.

HRT Financial reported no remaining GeoVax Labs position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 7,409 GeoVax Labs shares in Q1 2026, an estimated $31K.
HRT Financial first reported a position in GeoVax Labs in Q3 2022 and held it in 2 quarters.
HRT Financial's GeoVax Labs position peaked at $31K in Q4 2025.
16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.